Know Cancer

or
forgot password

Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk


N/A
18 Years
39 Years
Not Enrolling
Both
Breast Cancer, Ovarian Cancer

Thank you

Trial Information

Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk


Inclusion Criteria:



- Females and males who are carriers of deleterious mutations in the genes BRCA1 or
BRCA2.

- Over age 18 and:

1. For women, less than 43

2. For men, less than 50.

- Received genetic testing and counseling for BRCA.

- Fluent in English.

Exclusion Criteria:

- Patients who are currently under treatment (chemotherapy, radiation)

- Individuals who refuse to discuss reproductive issues.

- Unable to give informed consent due to physical, cognitive, or psychiatric disability

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

To explore the attitudes of BRCA1/2 mutation carriers about PGD/PND, most notably benefits and drawbacks, as well as ethical and emotional considerations;

Outcome Time Frame:

conclusion of study

Safety Issue:

No

Principal Investigator

Karen Hurley, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

06-137

NCT ID:

NCT00735150

Start Date:

March 2008

Completion Date:

October 2010

Related Keywords:

  • Breast Cancer
  • Ovarian Cancer
  • Breast
  • Ovary
  • Mutation carrier
  • Breast Neoplasms
  • Ovarian Neoplasms

Name

Location

Memorial Sloan-Kettering Cancer CenterNew York, New York  10021